Differential drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis.
Where this comes from
- Record sourced from PubMed, PMID 16699049.
- Also identified by PMC identifier 1798160.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A significant number of patients receiving infliximab require dosing adjustments while some patients may indeed develop drug resistance
Medical subject headings
- Antibodies, Monoclonal
- Antirheumatic Agents
- Arthritis, Rheumatoid
- Tumor Necrosis Factor-alpha